New autism therapy shows surprising benefits even in adult mice

Researchers have discovered a new autism therapy that has shown surprising benefits in adult mice by blocking the glycine transporter SLC6A20. This treatment restored important brain signaling and improved social, communication, and repetitive behaviors in autism-related mouse models. The therapy also demonstrated effectiveness in human brain organoids and had lasting effects in adult mice. This breakthrough suggests that the brain may remain more treatable later in life than previously thought, offering new hope for autism treatment.

✦ AI-generated summary